As of 2025-07-06, the Intrinsic Value of Titan Pharmaceuticals Inc (TTNP) is -88.63 USD. This TTNP valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.40 USD, the upside of Titan Pharmaceuticals Inc is -2,114.22%.
Based on its market price of 4.40 USD and our intrinsic valuation, Titan Pharmaceuticals Inc (TTNP) is overvalued by 2,114.22%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -88.63 - -88.63 | -88.63 | -2,114.22% |
| P/E | (67.02) - (89.78) | (77.70) | -1865.9% |
| DDM - Stable | (27.04) - (70.94) | (48.99) | -1213.5% |
| DDM - Multi | (21.78) - (46.84) | (29.99) | -781.6% |
| Market Cap (mil) | 4.00 |
| Beta | 0.08 |
| Outstanding shares (mil) | 0.91 |
| Enterprise Value (mil) | 2.06 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.97% |
| Cost of Debt | 5.00% |
| WACC | 8.82% |